BiltmoreBiweekly gemcitabine and carboplatin in first-line metastatic or recurrent nasopharyngeal carcinoma (NPC)–An early report

Citation:

BENSALEM A, Ammari A, touhami SK, Bouzid K. BiltmoreBiweekly gemcitabine and carboplatin in first-line metastatic or recurrent nasopharyngeal carcinoma (NPC)–An early report.; 2012.

Publications /Année

Submitted (11)
2024 (16)
2023 (28)
2022 (169)
2021 (473)
2020 (440)
2019 (553)
2018 (630)
2017 (522)
2016 (439)

Publications / Auteur